Top Clinical Trials companies in Finland by EBITDA
This ranking features the top 1 Clinical Trials companies in Finland ranked by EBITDA, totalling a EBITDA of USD -31.31 M, for January 15, 2025.
Finland
Clinical Trials
EBITDA
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -31.31 M
|
Dec. 31, 2023 | USD 2.50 | 2.59% |
|
Finland |
Frequently Asked Questions
-
Which Clinical Trials company in Finland has the highest EBITDA ?
The Clinical Trials company in Finland with the highest EBITDA is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -31.31 M.
-
Which Clinical Trials company in Finland has the lowest EBITDA ?
The Clinical Trials company in Finland with the lowest EBITDA is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -31.31 M.
-
What are the top 10 Clinical Trials companies in Finland by EBITDA ?
The top 10 Clinical Trials companies in Finland by EBITDA are and Faron Pharmaceuticals Oy.
-
What are the bottom 10 Clinical Trials companies in Finland by EBITDA ?
The bottom 10 Clinical Trials companies in Finland by EBITDA are and Faron Pharmaceuticals Oy.